IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v17y2020i3p1005-d316810.html
   My bibliography  Save this article

Exposure of CuO Nanoparticles Contributes to Cellular Apoptosis, Redox Stress, and Alzheimer’s Aβ Amyloidosis

Author

Listed:
  • Ying Shi

    (Neurochemistry Laboratory, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA)

  • Alexander R. Pilozzi

    (Neurochemistry Laboratory, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA)

  • Xudong Huang

    (Neurochemistry Laboratory, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA)

Abstract

Fe 2 O 3 , CuO and ZnO nanoparticles (NP) have found various industrial and biomedical applications. However, there are growing concerns among the general public and regulators about their potential environmental and health impacts as their physio-chemical interaction with biological systems and toxic responses of the latter are complex and not well understood. Herein we first reported that human SH-SY5Y and H4 cells and rat PC12 cell lines displayed concentration-dependent neurotoxic responses to insults of CuO nanoparticles (CuONP), but not to Fe 2 O 3 nanoparticles (Fe 2 O 3 NP) or ZnO nanoparticles (ZnONP). This study provides evidence that CuONP induces neuronal cell apoptosis, discerns a likely p53-dependent apoptosis pathway and builds out the relationship between nanoparticles and Alzheimer’s disease (AD) through the involvement of reactive oxygen species (ROS) and increased Aβ levels in SH-SY5Y and H4 cells. Our results implicate that exposure to CuONP may be an environmental risk factor for AD. For public health concerns, regulation for environmental or occupational exposure of CuONP are thus warranted given AD has already become a pandemic.

Suggested Citation

  • Ying Shi & Alexander R. Pilozzi & Xudong Huang, 2020. "Exposure of CuO Nanoparticles Contributes to Cellular Apoptosis, Redox Stress, and Alzheimer’s Aβ Amyloidosis," IJERPH, MDPI, vol. 17(3), pages 1-18, February.
    • Handle: RePEc:gam:jijerp:v:17:y:2020:i:3:p:1005-:d:316810
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/17/3/1005/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/17/3/1005/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Mark P. Mattson, 2004. "Addendum: Pathways towards and away from Alzheimer's disease," Nature, Nature, vol. 431(7004), pages 107-107, September.
    2. Mark P. Mattson, 2004. "Pathways towards and away from Alzheimer's disease," Nature, Nature, vol. 430(7000), pages 631-639, August.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Ngoumen Ngassa Dany Joel & Ngondi Judith Laure & Oben Julius Enyong, 2021. "Effect of Autranella congolensis on Lipid Profile of Rats' Brain with Experimentally Induced Alzheimer's Disease," Journal of Food Research, Canadian Center of Science and Education, vol. 9(4), pages 1-60, December.
    2. Gema Lordén & Jacob M. Wozniak & Kim Doré & Lara E. Dozier & Chelsea Cates-Gatto & Gentry N. Patrick & David J. Gonzalez & Amanda J. Roberts & Rudolph E. Tanzi & Alexandra C. Newton, 2022. "Enhanced activity of Alzheimer disease-associated variant of protein kinase Cα drives cognitive decline in a mouse model," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    3. Shu Jiang & Yijun Xie & Graham A. Colditz, 2021. "Functional ensemble survival tree: Dynamic prediction of Alzheimer’s disease progression accommodating multiple time‐varying covariates," Journal of the Royal Statistical Society Series C, Royal Statistical Society, vol. 70(1), pages 66-79, January.
    4. Seyed-Ali Sadegh-Zadeh & Chandrasekhar Kambhampati, 2018. "Computational Investigation of Amyloid Peptide Channels in Alzheimer’s Disease," J, MDPI, vol. 2(1), pages 1-14, December.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:17:y:2020:i:3:p:1005-:d:316810. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.